Evogene (EVGN) Inventory (2021 - 2025)
Evogene (EVGN) posted Inventory of $210000.0 for Q4 2025, down 90.05% sequentially from $2.1 million in Q3 2025, and down 88.46% YoY from $1.8 million in Q4 2024.
Evogene (EVGN) Inventory (2021 - 2025) Analysis & Trends
Evogene has reported Inventory for 5 years, with the latest figure at $210000.0 in Q4 2025.
- Quarterly Inventory fell 88.46% year-over-year to $210000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $210000.0 (down 88.46% YoY) and the FY2025 annual result came in at $210000.0, down 88.46% from the prior year.
- Inventory slipped to $210000.0 in Q4 2025 per EVGN's latest filing, from $2.1 million in the prior quarter.
- Over five years, Inventory peaked at $2.2 million in Q1 2025 and troughed at $76000.0 in Q4 2023.
- A 5-year average of $788176.5 and a median of $566000.0 in 2022 frame the typical range for Inventory.
- The sharpest annual moves came in 2024 and 2025: Inventory surged 2293.42% in 2024, then slumped 88.46% in 2025.
- Over 5 years, Inventory stood at $92000.0 in 2021, then jumped by 515.22% to $566000.0 in 2022, then slumped by 86.57% to $76000.0 in 2023, then soared by 2293.42% to $1.8 million in 2024, then plunged by 88.46% to $210000.0 in 2025.
- According to Business Quant data, Inventory over the past three periods registered $210000.0, $2.1 million, and $2.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 280.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 732.60 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 97.11 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 128.86 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 142.38 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Evogene | 4.38 Mn | 4.38 Mn | 204,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 210,000.00 |
| Sep 30, 2025 | 2.11 Mn |
| Jun 30, 2025 | 1.96 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 1.82 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 794,000.00 |
| Mar 31, 2024 | 716,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Sep 30, 2023 | 113,000.00 |
| Jun 30, 2023 | 249,000.00 |
| Mar 31, 2023 | 591,000.00 |
| Dec 31, 2022 | 566,000.00 |
| Sep 30, 2022 | 165,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 92,000.00 |